Navigation Links
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Date:2/28/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...y researchers from the National Evolutionary Synth...ealed how reproductive speed prevents large grazi...ularly hunted by humans, from becoming extinct. T...t loss and living in a limited geographic area doe...
...searchers suggest that hormones in saliva may be a...suffer as a result of chronic bullying by peers. ...id in the early recognition and intervention of lo...effects on youth. 'Bullying is mainly self-repor...
...y of Rhode Island's Cancer Prevention Research Cen...en to prevent them from substance abuse . The outc... helping to change smoking and other high-risk beh... University received a $3.5 million, 5-year grant ...
...rtage of allergists in the US may soon impact the ...gic diseases, according to a report. Without int...lists is projected to decline by 7 percent while d...35 percent over the next dozen years, said ACAAI P...
Other Medicine News:Health News:Extinction Risk of Grazing Animals Depends on Reproductive Speed 2Health News:Saliva Helps to Identify Child Victims of Chronic Bullying 2Health News:New Substance Use Prevention Program Being Developed 2Health News:New Substance Use Prevention Program Being Developed 3Health News:New Substance Use Prevention Program Being Developed 4Health News:America on Brink of Allergy Crisis 2
(Date:9/4/2008)...arded orphan designation for the treatment of Acut... PRINCETON, N.J., Sept. 4 /- Celator...d & Drug Administration (FDA) has granted orphan,d...n) Liposome Injection,for the treatment of Acute M...aring to conduct two randomized Phase 2,studies wi...
(Date:9/4/2008)...M, Ala., Sept. 4 /- Southern Research...tutes of Health (NIH) has selected,the organizatio...raries,Probe Production Center Network (MLPCN). Th...part of the Molecular Libraries Program which is,d...c knowledge of the human,genome and validate futur...
(Date:9/4/2008)...ptimizing Patient Identification for Targeted Ther...lized Treatment HUNTINGTON BEACH, Calif., and A...ndia, a world leader in molecular cancer diagnosti...a new diagnostic test that,allows physicians to qu...of,the estrogen receptor (ER), progesterone recept...
(Date:9/3/2008)...n College of Rheumatology Research and Education F...ificant Advances in Detecting, .../- For the first time during its,unpr... arthritis, the,American College of Rheumatology R...information acquired from research funded by the W...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Daytime Sleeping Linked to Poor Recovery in Older Patients 25926 1Daytime Sleeping Linked to Poor Recovery in Older Patients 25926 2American Chemical Societys Weekly PressPac Aug 27 2008 4664 1American Chemical Societys Weekly PressPac Aug 27 2008 4664 2American Chemical Societys Weekly PressPac Aug 27 2008 4664 3American Chemical Societys Weekly PressPac Aug 27 2008 4664 4American Chemical Societys Weekly PressPac Aug 27 2008 4664 5American Chemical Societys Weekly PressPac Aug 27 2008 4664 6American Chemical Societys Weekly PressPac Aug 27 2008 4664 7American Chemical Societys Weekly PressPac Aug 27 2008 4664 8China Pharma Holdings Inc Will Attend the Susquehanna Financial Group LLP 28SIG 29 Beijing Management Summit 7402 1Keep Eyes Safely On The Ball 25919 1Keep Eyes Safely On The Ball 25919 2Keep Eyes Safely On The Ball 25919 3
... Activity and Patient Tolerance Support Developmen...ELONA, Spain, April 12, 2007 /PRNewswire/ -- Intar...ceutical company,today announced final results fr...hout ribavirin in treatment-naive patients,with ge...ate that,omega interferon in combination with riba...
...CISCO, Calif., April 11, 2007 (PRIME NEWSWIRE) --,...l company focused,on advancing cancer care, will p...in) for Injection at the American Association,for ...2007 in Los,Angeles, California. , Abstract No. 22... in A549 non-small cell lung cancer (NSCLC) athymi...
Other Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3
Angled 13.5 mm adjustable blades. Teeth in lower jaws fit into holes in upper jaws. Grooves in lower jaw for passage of suture needles. Round knurled handle with polished finish.
Multi-curved shafts with straight blades and longitudinal serrations. Slide lock and serrated handle with polished finish. Blade length: 27 mm.
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish.
Smooth pointed tips open to 3.0 mm. Straight shafts. Cross action. Round handle.
Medicine Products: